About Q2-2024 report by CEO Johan Wäborg at Carnegie

Iconovo released the Q2-2024 report today and the CEO at Iconovo, Johan Wäborg was invited to the Carnegie Bank studio to comment and give some more flavor…

Iconovo releases Q2-2024 report

“A quarter of intense business development and constructive negotiations." says Johan Wäborg, CEO at Iconovo. CEO MESSAGES:  STRATEGIC INITIATIVES…

Dr Orest Lastow presenting Systemic Delivery of Biologics via Inhalation: Overcoming Injection Aversion in Modern Therapies

Iconovo to present at New Updates in Drug Formulation & Bioavailability in Copenhagen August 28th. Dr Orest Lastow, CTO at Iconovo will present on…

Iconovo attends Carnegie Healthcare Webinar

Iconovo CEO Johan Wäborg gives a company presentation at Carnegie Healthcare Webinar. In the video you can hear him go through the company, the strategies…

ICONOVO AB PUBLISHES THE ANNUAL REPORT 2023 IN ENGLISH

The abbreviated annual report 2023 in English is available using the link below. To read abbreviated Annual Report in English.

Iconovo files patent application for inhaled GLP-1 products and initiates development of new obesity treatments

Iconovo AB (publ), which develops complete inhalation products for a global market, today announces that the company has filed a broad patent application…

Iconovo releases Q1-2024 report

“We have made a flying start into 2024.”, says Johan Wäborg, CEO at Iconovo. CEO's MESSAGES. - RAMPING UP IN 2024 - ICONOVO EXPANDS BUSINESS…

Iconovo’s partner Monash University has completed enrollment in a Phase I clinical trial of inhaled oxytocin in ICOone

Iconovo AB (publ), which develops complete inhalation products for a global market, today announces that the clinical phase I study of oxytocin in…

Iconovo to present positive data from a feasibility study on Nanofitins in ICOone

Iconovo AB and Affilogic today announce that Iconovo will present positive results from a feasibility study with a Nanofitin based biologic drug against…

Iconovo receives grant of SEK 680,000 from Innowwide for market efforts in South Korea

Iconovo announces that the company will receive a grant of SEK 680,000 from Innowwide. The grant will be used to carry out a market study to introduce…